WO2016038221A1 - Composition de chitosane - Google Patents

Composition de chitosane Download PDF

Info

Publication number
WO2016038221A1
WO2016038221A1 PCT/EP2015/070903 EP2015070903W WO2016038221A1 WO 2016038221 A1 WO2016038221 A1 WO 2016038221A1 EP 2015070903 W EP2015070903 W EP 2015070903W WO 2016038221 A1 WO2016038221 A1 WO 2016038221A1
Authority
WO
WIPO (PCT)
Prior art keywords
chitosan
cross
composition
water
oil
Prior art date
Application number
PCT/EP2015/070903
Other languages
English (en)
Inventor
Mats Andersson
Louise ZETTERGREN
Original Assignee
Viscogel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viscogel Ab filed Critical Viscogel Ab
Publication of WO2016038221A1 publication Critical patent/WO2016038221A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113Multiple emulsions, e.g. oil-in-water-in-oil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition d'émulsion pharmaceutique comprenant : (i) un hydrogel de chitosane comprenant du chitosane réticulé et de l'eau, ledit hydrogel de chitosane pouvant être obtenu en faisant réagir du chitosane désacétylé de manière aléatoire ayant un degré de désacétylation de 30 à 75 % et un agent de réticulation ; et (ii) une émulsion d'eau dans l'huile dispersée dans l'hydrogel, ladite huile étant une huile pharmaceutiquement acceptable, ladite eau contenant un principe actif pharmaceutique, et ladite émulsion d'eau dans l'huile comprenant en outre un émulsifiant. La présente invention concerne également un procédé de préparation de ladite composition consistant à : (i) utiliser une composition de chitosane réticulable comprenant un chitosane désacétylé de manière aléatoire ayant un degré de désacétylation de 30 à 75 %, un agent de réticulation et de l'eau ; (ii) disperser une émulsion d'eau dans l'huile dans la composition, ladite huile étant une huile pharmaceutiquement acceptable, ladite eau contenant un principe actif pharmaceutique, et ladite émulsion d'eau dans l'huile comprenant en outre un émulsifiant ; et (iii) réticuler la composition de chitosane réticulable pour former un hydrogel, avant, pendant ou après l'étape (ii).
PCT/EP2015/070903 2014-09-11 2015-09-11 Composition de chitosane WO2016038221A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1416080.8 2014-09-11
GBGB1416080.8A GB201416080D0 (en) 2014-09-11 2014-09-11 Chitosan composition

Publications (1)

Publication Number Publication Date
WO2016038221A1 true WO2016038221A1 (fr) 2016-03-17

Family

ID=51869460

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2015/070903 WO2016038221A1 (fr) 2014-09-11 2015-09-11 Composition de chitosane

Country Status (2)

Country Link
GB (1) GB201416080D0 (fr)
WO (1) WO2016038221A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017177265A1 (fr) * 2016-04-12 2017-10-19 Capsular Technologies Pty Ltd Composition injectable pour l'administration d'un agent biologiquement actif
CN109603765A (zh) * 2018-12-14 2019-04-12 陕西师范大学 一种低聚壳聚糖磁珠的、制备方法及其应用
CN113461968A (zh) * 2021-08-04 2021-10-01 河南工业大学 一种羧甲基壳聚糖稳定的高内相乳液及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130184356A1 (en) * 2010-05-04 2013-07-18 Viscogel Ab Chitosan composition

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130184356A1 (en) * 2010-05-04 2013-07-18 Viscogel Ab Chitosan composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HINO T ET AL: "Drug release from w/o/w emulsions prepared with different chitosan salts and concomitant creaming up", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 69, no. 3, 3 December 2000 (2000-12-03), pages 413 - 419, XP004221291, ISSN: 0168-3659, DOI: 10.1016/S0168-3659(00)00322-9 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017177265A1 (fr) * 2016-04-12 2017-10-19 Capsular Technologies Pty Ltd Composition injectable pour l'administration d'un agent biologiquement actif
CN109310632A (zh) * 2016-04-12 2019-02-05 封装技术私人有限公司 用于递送生物活性剂的可注射组合物
EP3442503A4 (fr) * 2016-04-12 2019-11-20 Capsular Technologies Pty Ltd. Composition injectable pour l'administration d'un agent biologiquement actif
US10905649B2 (en) 2016-04-12 2021-02-02 Capsular Technologies Pty Ltd Injectable composition for delivery of a biologically active agent
AU2017250005B2 (en) * 2016-04-12 2022-12-22 Swinburne University Of Technology Injectable composition for delivery of a biologically active agent
CN109603765A (zh) * 2018-12-14 2019-04-12 陕西师范大学 一种低聚壳聚糖磁珠的、制备方法及其应用
CN109603765B (zh) * 2018-12-14 2021-07-16 陕西师范大学 一种低聚壳聚糖磁珠的、制备方法及其应用
CN113461968A (zh) * 2021-08-04 2021-10-01 河南工业大学 一种羧甲基壳聚糖稳定的高内相乳液及其制备方法
CN113461968B (zh) * 2021-08-04 2024-04-12 河南工业大学 一种羧甲基壳聚糖稳定的高内相乳液及其制备方法

Also Published As

Publication number Publication date
GB201416080D0 (en) 2014-10-29

Similar Documents

Publication Publication Date Title
US9555120B2 (en) Chitosan composition
Sharkawy et al. Chitosan-based Pickering emulsions and their applications: A review
CN110200925B (zh) 氧化纤维素微球体和组合物
US8703924B2 (en) Chitosan composition
AU2008337407B2 (en) Crosslinked hyaluronic acid in emulsion
ES2604120T3 (es) Composición que comprende una fase interna dispersada en una fase continua hidrófila
Di Martino et al. Chitosan grafted low molecular weight polylactic acid for protein encapsulation and burst effect reduction
Pal et al. Chitosan based delivery systems on a length scale: Nano to macro
Wu et al. Hydrophobically modified polysaccharides and their self-assembled systems: A review on structures and food applications
JP2014521492A (ja) 注入充填剤(フィラー){injectablefiller}
EP2018154B1 (fr) Suspension d'hydrogel et son procédé de fabrication
Grant et al. Self-assembly and physicochemical and rheological properties of a polysaccharide− surfactant system formed from the cationic biopolymer chitosan and nonionic sorbitan esters
WO2016038221A1 (fr) Composition de chitosane
Ali et al. Chitosan-Shea butter solid nanoparticles assemblies for the preparation of a novel nanoparticles in microparticles system containing curcumin
US20120201862A1 (en) Process for the preparation of colloidal systems for the delivery of active compounds
Raghav et al. Recent advances in cellulose, pectin, carrageenan and alginate-based oral drug delivery systems
WO2015032984A1 (fr) Composition de chitosane
US20230102859A1 (en) Natural origin stabilizer for oil in water emulsions
Bhutto et al. Curcumin-loaded Pickering emulsion stabilized by pH-induced self-aggregated chitosan particles: Effects of degree of deacetylation and molecular weight
Tivano et al. Zein as a renewable material for the preparation of green nanoparticles for drug delivery
Hooda et al. Chitosan nanoparticles: A marine polysaccharide for biomedical research
Victor et al. Chitosan self-aggregates and micelles in drug delivery
Ma et al. From Nature‐Sourced Polysaccharide Particles to Advanced Functional Materials
ES2371898A1 (es) Nanogeles de ciclodextrina.
Fischer Sustainability in Drug and Nanoparticle Processing

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15763317

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15763317

Country of ref document: EP

Kind code of ref document: A1